Immune modulations in the context of LOX and cancer so far have been primarily documenting elevated expression levels of increased LOX enzyme activity and its relationships to increased tissue stiffness due to increased collagen cross-linking and fibrosis [32,33,34]. This evidence concerns the gene LOX and cancer.